Objectives

After participating in this educational activity, attendees should be able to

1. 1| Discuss the incidence, patient safety factors, and cost of NVHAP.
2. 2| Discuss the etiology and risk factors for NVHAP and the impact on patient outcomes
3. 3| Explain the role of interventional nursing services in the prevention of NVHAP
4.  

Faculty

Karen K. Giuliano, PhD, RN, MBA
Nurse Scientist, Baystate Medical Center
Professor (Joint), College of Nursing & Institute for Applied Life Sciences
Elaine Marieb Center for Nursing and Engineering Innovation
 

Dian Baker, PhD, MA, MS, APRN
Professor Emeritus, California State University, Sacramento
DB Consulting, LLC
 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

Dr. Giuliano receives research funding and consulting from ICU Medical and Stryker Medical, Consultant for RF Health, GE Healthcare

Dr. Baker is a consultant for Stryker, an Educator for Avanos, Supplied products for research for GUM/Sunstar and receives researching funding from Delta Dental Illinois.

Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Nurses
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 contact hour(s).  Nurses should only claim the credit commensurate with the extent of their participation in the activity.